Substances · Phenethylamine derivatives
6-MAPB
- Preferred name
- 6-MAPB
- IUPAC name
- 1-(1-benzofuran-6-yl)-N-methylpropan-2-amine
- Parent CAS number (reference)
- 1354631-79-0
- Molecular formula
- C12H15NO
- Molecular weight
- 189.25 g/mol
- InChIKey
- QLAAURQYEAEHBO-UHFFFAOYSA-N
- PubChem
- CID 122202866
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
6-(2-Methylaminopropyl)benzofuran 6MAPB 6 MAPB
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
6-MAPB
Receptor Telemetry & Mechanism of Action
6-MAPB is the N-methyl analogue of 6-APB, in the same structural relationship as MDMA to MDA or 5-MAPB to 5-APB. It is a serotonin-leaning entactogen, generally described as smoother and less stimulating than 6-APB, with the same rule against stacking other releasers. 5-HT2B agonism remains relevant for the benzofuran class when use is repeated. PsychonautWiki does not publish a standalone dose table for 6-MAPB; the oral bands below are the TripSit light/common/strong/heavy figures.
Biotransformation & Active Metabolites
Not a prodrug of 6-APB or MDMA. The freebase parent is C12H15NO, 189.25 g/mol, the same formula and mass as 5-MAPB (CAS 1354631-77-8) and a different CAS (1354631-79-0). Position 5 versus position 6 is the identity, not the molecular weight. Salt form still changes the weighed mass.
Temporal Pharmacokinetics
Smoother, less stimulating entactogen than 6-APB, still serotonergic, with a long tail and a flat next day.
- Onset 30–60 minutes (aligned with oral 6-APB; a separate 6-MAPB onset table is not on PsychonautWiki)
- Peak Window several hours inside a 5–10 hour total
- Total Window 5–10 hours (TripSit / secondary oral summaries)
- Residual / Half-Life After-effects 2–4 hours at minimum, with a serotonergic low mood that can last longer, as with 5-MAPB and 6-APB. Human half-life is not established.
TripSit oral light 20–40 mg, common 40–80 mg, strong 80–100 mg, heavy above 100 mg. A threshold just under the light band is about 15–20 mg. The common band is wide. 80 mg is already the top of common and the start of strong. Do not import the 6-APB strong band (90–120 mg) or the 5-MAPB hydrochloride adjustment onto this name without knowing the salt.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
15–20 mg
A mild mood change at the bottom edge of the TripSit light band.
Slight body warmth.
20–40 mg
Gentle empathy and calm stimulation.
Jaw awareness, reduced appetite, and mild pupil dilation.
40–80 mg
Clear entactogenic warmth, tactile enhancement, and less psychedelic overlay than 6-APB.
Bruxism, sweating, and a moderate rise in heart rate.
80–100 mg
Intense emotional openness with growing anxiety or restlessness and little extra benefit.
Stronger cardiovascular load, nausea, and hyperthermia risk.
100 mg+
Overwhelmed and toxic rather than pleasantly empathic.
Hyperthermia, hypertension, and serotonin toxicity if MDMA, 5-MAPB, or 4-FA is added.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
6-MAPB is itself a serotonin releaser. Combinations are serotonin-syndrome and hyperthermia combinations.
Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.
Elevated Hazard — Avoid
Added cardiovascular strain and seizure risk.
Dehydration and poor judgment across a 5–10 hour course.
Caution / Receptor Attenuation
Blunt warmth without removing risk from a second releaser.
Both are C12H15NO, 189.25 g/mol. CAS 1354631-79-0 is 6-MAPB. CAS 1354631-77-8 is 5-MAPB. Their oral common bands are not the same document.
Structural Isomer & Sibling Comparison
6-MAPB is the N-methyl, 6-position entactogen. TripSit common oral is 40–80 mg, versus PsychonautWiki 60–90 mg for 6-APB and 60–80 mg for 5-MAPB. It is usually less stimulating and less visual than 6-APB and a bit less 'classic MDMA' than 5-MAPB. The shared formula with 5-MAPB is an identity trap, the same kind as 3-FA versus 4-FA. 5-HT2B caution and the ban on stacked releasers apply to all three.
Physicochemical Stability & Storage
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
Serotonergic tolerance and cross-tolerance with MDMA, 5-MAPB, and 6-APB. Because PsychonautWiki gives 6-APB a multi-week reset, 6-MAPB should be spaced in that same way rather than treated as a milder drug that can be repeated sooner. The crash is fatigue and low mood. repeated exposure across the wide 40–80 mg common band is how people arrive at 100 mg without planning to.
Chemical Architecture & Structural Profile
6-MAPB (1-(1-benzofuran-6-yl)-N-methylpropan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C12H15NO and a molar mass of 189.25 g/mol. The parent molecule is indexed under CAS registry number 1354631-79-0 and in the NCBI PubChem database as CID 122202866 (Standard InChIKey: QLAAURQYEAEHBO-UHFFFAOYSA-N). This molecule shares its empirical formula (C12H15NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1354631-79-0), and spectroscopic profile.
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 6-MAPB is indexed within the Phenethylamine derivatives structural group. Substituted phenethylamine derivative; documented reference precautions highlight hazardous interactions with MAOIs, tramadol, and lithium salts. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (IE) — National Regulatory Authority (IE) (2026-11-12)